HOSPITAL ACQUIRED INFECTION

What we know
What information do we have about the Eastern Board area?
What is the result of this on our health locally?
Policies
What is happening in the Eastern Board area?

 

Statistics
Click here for Statistics

 
Links
Click here for Links
 
Documents
Click here for Documents
What we know

In recent years there has been considerable concern about the frequency of infections acquired by patients while they are in hospital. This is despite improved methods of sterilisation of equipment and wider adoption of aseptic techniques. The factors involved in this include:

The emergence of resistant strains of organisms, partly due to the increased used of antibiotics;
The increased survival of patients with life threatening illnesses who are more susceptible to infection;
The wider use and complexity of surgical procedures;
The advent of modern therapies, such as immunosuppressive drugs, which lower resistance to infection.


Back to top

What information do we have about the Eastern Board area?

The Communicable Disease Surveillance Centre Northern Ireland records instances of Methicillin-resistant Staphylococcus Aureus (MRSA). Between April 2004 and March 2005, there were 242 patient episodes recorded of MRSA Bacteraemia in Northern Ireland, 143 of which were in hospitals in the Eastern Board area. It is important to note, however, that there is a concentration of hospital Trusts in the Eastern Board area, many of which provide regional services.  This illustrates a reduction of 21% in Northern Ireland and from the same period in 2003/04

Back to top

What is the result of this on our health locally?

Urinary and wound infections, that are especially likely to develop when a patient is in hospital, tend to be endogenous (i.e. a break in the patient’s natural body defences causes the patient’s own normal bacterial flora to induce infection). Hospital acquired infections often increase the length of stay in hospital with economic implications for the individual and the health service.

One infection which has caused increased concern recently is Methicillin-resistant Staphylococcus Aureus (MRSA). The main problem with MRSA in the hospital setting is that staff or patients who carry the bacteria represent a risk to other patients. Staphylococcus aureus is a skin commensal which is carried by about 30% of the population. All staphylococci, including MRSA, are easily spread by direct contact and persist in the environment. Where patients are being constantly moved between wards and from nursing homes into hospital MRSA can spread very quickly. The primary problem in hospital is therefore one of cross infection. MRSA can cause deep-seated wound infections that prove very difficult to treat. Hospital outbreaks of MRSA can be difficult to control. Effective control measures include identifying and treating carriers, isolating those with infection and strict adherence to stringent hygiene policies in hospitals including rigorous environmental cleaning.


Back to top

Policies

The Department of Health in England has published various guidance and established a range of national advisory structures and expert committees to increase the priority given to hospital acquired infection. These include “Winning Ways – Working together to reduce healthcare infection in England – report from the CMO” (2003) and “Towards cleaner hospitals and lowers rates of infection” (2004).

The Welsh Assembly developed “Hospital associated infections – A strategy for hospitals in Wales” (2004).

The Scottish Assembly developed “Preventing infections acquired while receiving health care – the Scottish Executive’s action plan to reduce the risk to patients, staff and visitors 2002-2005”.

The National Institute for Clinical Excellence (NICE) guidance on infection control makes recommendations on the standard principles for preventing healthcare associated infections and on measures for preventing infections (“Infection control: prevention of healthcare-associated infection in primary and secondary care”).

Back to top

What is happening in the Eastern Board area?

In Northern Ireland an Infection Control Strategy is being developed. Infection control is a high priority, with Trusts making improvements to their infection control management arrangements to reduce the risk of hospital acquired infection.
The Communicable Disease Surveillance Centre Northern Ireland, which is part of the UK Health Protection Agency, provides a regional service which includes:

Surveillance of communicable disease;
Advice and support to DHSSPS, Health and Social Services Boards and Trusts;
Advice and support to professionals;
Training and the promotion of professional standards;
Research.


At national level the Health Protection Agency (HPA), in association with the NHS and other organisations:

monitors and investigates the occurrence of infection within the population;
provides specialist and reference laboratory services for the detection of infectious agents in people, food and the environment;
investigates outbreaks of disease and coordinates the response to major epidemics or other infectious disease emergencies;
provides authoritative information and advice to government, professionals and the public;
manufactures vaccines and undertakes studies of the safety and effectiveness of these and other products;
improves knowledge through research and development, education and training.


Back to top

 

For further information on this topic please contact us at publichealth@ehssb.n-i.nhs.uk

Eastern Health and Social Services Board Champion House, 12-22 Linenhall Street, Belfast BT2 8BS Telephone: (028) 9032 1313 Fax: (028) 9055 3681 Text Phone:(028) 9032 4980 Website: www.ehssb.org E-mail: pr@ehssb.n-i.nhs.uk
Site designed by areema.co.uk